about
Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibodyRecombinant retroviral DNA yielding high expression of hepatitis B surface antigen.Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line.Concentration and purification of hepatitis B antigen with polyethylene glycol and polyelectrolyte 60, a cross-linked copolymer of isobutylene maleic anhydride.Purification and biophysical characterization of hepatitis B antigenAustralia antigen and antibody in transfused children with thalassaemiaBiochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.Proteins of hepatitis B surface antigenMajor polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid.Australia antigen: large-scale purification from human serum and biochemical studies of its proteinsDNA polymerase associated with human hepatitis B antigen.Electron microscopic observations and speculations on Australia antigenEnhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector.Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.Microtiter solid-phase radioimmunoassay for hepatitis B antigen.Demonstration of subpopulations of Dane particles.Expression of hepatitis B surface antigen with a recombinant adenovirus.Serology and epidemiology.Serum hepatitis as a persistent infection.Australia antigen and heaptitis: a review.Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus.Comparison of the reversed passive hemagglutination with radioimmunoassay methods for hepatitis B antigen.Reduction and reoxidation of Australia antigen: loss and reconstitution of particle structure and antigenicity.Co-transcribed 3' host sequences augment expression of integrated hepatitis B virus DNA.
P2860
Q27486291-2E05FB9B-571E-40AC-9B7E-4B05EC160342Q33928305-763BDF65-BE21-4BE7-B22C-636FB6A3B095Q33928913-2AB0705E-74CD-4DB1-A605-F8A782C0C953Q34477081-27483C88-E6B5-465A-A7FA-2A5CDDB2F15FQ34504100-5B45D97C-B9A4-460D-937B-9BA45BF5EBADQ35150011-500A7212-8563-4C22-BC27-C930705486DFQ36077607-F2E5F55C-DDAC-4C54-A8DE-862240AE450CQ36099144-30B16663-2F51-4D02-9247-A322AE0FDF94Q36512139-CF4F190A-7D7D-426E-BC83-A6A529137108Q36563901-9B5EF2F8-5CEA-4B3B-A565-4BFDCF8641B4Q36579854-0691C23E-34E9-4982-96EE-D1617CCD5CF1Q36595122-A6D01433-0ACD-4A63-B9BC-8C900F166CD2Q36771891-3E686DAE-CB7D-4BEF-9F5F-8A8FE5255008Q36939666-9B9B91A9-C8B0-4701-AAFC-330634C1B3D9Q37108044-E5000322-FEC0-4101-9C7B-9CB9E7D1B337Q37233665-25AC8C6A-70B6-4D96-A6D5-3D81E0A3462FQ37500259-74859000-89E0-42B0-B1B9-F28FBFF6FE32Q37554507-838271CE-4A7A-4B3D-B3A3-BBDC5EE5078EQ39344531-366428C0-A3F4-497F-AFA0-AE3D6F3D3774Q39952741-B84A3514-DFF7-4A3D-8E56-BA94AB12D8C1Q40015263-45E04172-7C9A-4E8D-B525-698989E993AAQ40140203-82CF2424-D27A-48C0-8BB8-66754C6B0B97Q40233652-D61632E7-E6A2-4291-A51B-F3FEFEBEEE80Q40635727-A07AFE4B-3AE0-4053-AD36-213DA1B48E9EQ41379845-60ECBE60-F3D6-45C4-8D87-461363D04D2D
P2860
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Biophysical properties of Australia antigen.
@en
Biophysical properties of Australia antigen.
@nl
type
label
Biophysical properties of Australia antigen.
@en
Biophysical properties of Australia antigen.
@nl
prefLabel
Biophysical properties of Australia antigen.
@en
Biophysical properties of Australia antigen.
@nl
P2093
P2860
P1433
P1476
Biophysical properties of Australia antigen.
@en
P2093
P2860
P304
P407
P577
1969-11-01T00:00:00Z